Clinical decision making when cytology indicates a Warthin tumor.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 04 2024
Historique:
received: 01 11 2023
accepted: 04 04 2024
medline: 19 4 2024
pubmed: 18 4 2024
entrez: 17 4 2024
Statut: epublish

Résumé

Warthin tumor (WT) is a benign tumor usually affecting the parotid gland. The main diagnostic tool remains ultrasound combined with fine-needle aspiration cytology (FNAC). This study aims to examine how reliably FNAC indicates WT for clinical decision making regarding surgical versus conservative management. We included all patients who underwent FNAC from a parotid gland lesion between 2016 and 2018 at our institution, and whose FNAC revealed WT suspicion. The FNACs were divided into three groups based on the cytology report: certain, likely, and possible WT. The patients were divided into two groups based on having had either surgery or follow-up. We sent a questionnaire to patients who had not undergone surgery in order to obtain follow-up for a minimum of four years. Altogether, 135 FNAC samples, from 133 tumors and 125 patients, showed signs of WT. Of the 125 patients, 44 (35%) underwent surgery, and 81 (65%) were managed conservatively. Preoperative misdiagnosis in FNAC occurred in three (7%) surgically treated tumors. Their FNACs were reported as possible WTs, but histopathology revealed another benign lesion. In the conservatively treated group, two patients underwent surgery later during the follow-up. Cytological statements of WT were seldom false, and none were malignant. The majority of the patients were only followed-up and rarely required further treatment. A certain or likely diagnosis of WT in the FNAC report by an experienced head and neck pathologist is highly reliable in selecting patients for conservative surveillance.

Identifiants

pubmed: 38632256
doi: 10.1038/s41598-024-58892-0
pii: 10.1038/s41598-024-58892-0
pmc: PMC11023945
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8832

Informations de copyright

© 2024. The Author(s).

Références

Cancer Cytopathol. 2020 May;128(5):348-358
pubmed: 32022995
Int Arch Otorhinolaryngol. 2021 Jul;25(3):e379-e382
pubmed: 34377171
Otolaryngol Head Neck Surg. 1999 Jun;120(6):834-40
pubmed: 10352436
Head Neck. 2020 Mar;42(3):522-529
pubmed: 31762130
Cancer Cytopathol. 2022 Sep;130(9):714-725
pubmed: 35617489
Head Neck. 2017 Jan;39(1):170-176
pubmed: 27131221
J Med Case Rep. 2019 Jan 14;13(1):12
pubmed: 30636634
J Oral Maxillofac Pathol. 2016 May-Aug;20(2):224-9
pubmed: 27601813
Head Neck. 2019 Feb;41(2):358-365
pubmed: 30548147
Head Neck. 2010 Dec;32(12):1635-40
pubmed: 20848407
Ear Nose Throat J. 2016 Apr-May;95(4-5):185-8
pubmed: 27140020
Br J Surg. 1996 Dec;83(12):1750-4
pubmed: 9038559
J Pathol. 1985 May;146(1):51-8
pubmed: 4009321
Laryngoscope Investig Otolaryngol. 2020 Jul 20;5(4):694-702
pubmed: 32864441
Otolaryngol Head Neck Surg. 2006 Apr;134(4):646-9
pubmed: 16564390
Br J Oral Maxillofac Surg. 2010 Jan;48(1):26-9
pubmed: 19233526
Cytopathology. 2010 Jun;21(3):164-9
pubmed: 19744189
Cytopathology. 2020 May;31(3):193-207
pubmed: 32259367
J Appl Oral Sci. 2016 Nov-Dec;24(6):561-567
pubmed: 28076460
Korean J Pathol. 2012 Dec;46(6):569-75
pubmed: 23323108
Head Neck. 2022 Oct;44(10):2277-2287
pubmed: 35586869
Clin Otolaryngol Allied Sci. 1989 Jun;14(3):205-10
pubmed: 2743609
Diagn Cytopathol. 2018 Jul;46(7):613-619
pubmed: 29399982
Clin Otolaryngol. 2018 Apr;43(2):632-637
pubmed: 29178364

Auteurs

Minna Sirviö (M)

Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Kasarmikatu 11-13, FI-00029, Helsinki, Finland. minna.m.sirvio@hus.fi.

Katri Aro (K)

Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Kasarmikatu 11-13, FI-00029, Helsinki, Finland.

Mira Naukkarinen (M)

Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Kasarmikatu 11-13, FI-00029, Helsinki, Finland.

Antti Mäkitie (A)

Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Kasarmikatu 11-13, FI-00029, Helsinki, Finland.
Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Jussi Tarkkanen (J)

Pathology, Helsinki University Hospital Diagnostic Center, Helsinki, Finland.

Jetta Kelppe (J)

Pathology, Helsinki University Hospital Diagnostic Center, Helsinki, Finland.

Timo Atula (T)

Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Kasarmikatu 11-13, FI-00029, Helsinki, Finland.
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH